← Back to Search

Hybrid Contact Lens

Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses

N/A
Waitlist Available
Led By Paul Kusy, OD, MS, FAAO
Research Sponsored by SynergEyes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.

Eligible Conditions
  • Astigmatism
  • Transient Refractive Error
  • Refractive Errors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SynergEyes A2 Hybrid Contact LensExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

SynergEyes, Inc.Lead Sponsor
2 Previous Clinical Trials
98 Total Patients Enrolled
Paul Kusy, OD, MS, FAAOPrincipal InvestigatorSynergEyes, Inc.
~8 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top